Remember Theranos, the high-tech medical startup that falsely claimed to be able to conduct a battery of tests with a single drop of blood? The Wall Street Journal reports that, after years of legal hassles, it’s finally throwing in the towel and closing for good. CEO David Taylor informed shareholders of the move in a letter, in which he described the company’s efforts to try and sell itself over the past four months – but to no avail. Now, it’s in debt to its creditor Fortress Investment Group, which loaned the firm $65 million last year. As part of the…
This story continues at The Next Web
https://ift.tt/2Cl2TI9 Abhimanyu Ghoshal September 05, 2018 at 03:00AM
No comments:
Post a Comment